Company intelligence / Profile preview

111° West Capital

Alpine, Wyoming, United States

Ownership: Private
Employees: ~7
Development stage: Other

Overview

111° West Capital is a private, active healthcare-focused investment firm rather than a therapeutic drug developer. The firm invests in commercial-stage and high-growth enterprise software and digital health companies that aim to improve healthcare delivery, operations, and related infrastructure. Its positioning emphasizes a hands-on model combining an investment team with an operator network to help portfolio companies scale revenue and execute toward exits. Based on available public information, 111° West Capital is best characterized as a healthcare technology investor with a focus on software-enabled healthcare businesses, not a biotech or pharmaceutical pipeline company.

Industry: Investors

Beyond the preview

Go deeper on 111° West Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 111° West Capital.

Explore the full profile